Charles River Laboratories demonstrates excellence in research and laboratory services through its dynamic executive leadership and comprehensive organizational structure [1]. The company maintains a strong presence in major financial markets, including regular engagement at the New York Stock Exchange, reflecting its commitment to transparent corporate governance [1].
The executive leadership team encompasses key positions that drive strategic direction and operational excellence:
- Chairman, President & Chief Executive Officer
- Corporate Executive Vice President & Chief Operating Officer
- Corporate Executive Vice President, Chief People Officer
- Corporate Senior Vice President & Chief Information Officer
- Corporate Executive Vice President, Corporate Development & Strategy
- Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer
- Corporate Senior Vice President & Chief Strategy Officer [1]
In the federal marketplace, Charles River maintains strategic positions through established contract vehicles and programs. The company operates under a GSA Multiple Award Schedule (MAS) contract [1] and participates in the National Cancer Institute (NCI) Grantee Program [2], providing essential research models and laboratory services to government institutions.
Quality management and regulatory compliance form the cornerstone of Charles River's operations, as evidenced by:
- FDA registrations for Blood and HCT/P operations
- AABB accreditation
- CLIA certification for laboratory testing
- Compliance with EMA guidelines and GMP requirements [3]
The company's commitment to environmental and social responsibility is demonstrated through several key affiliations:
- United Nations Global Compact (UNGC) Signatory (2024) [7]
- Science Based Targets initiative participation
- RE100 membership
- Pharmaceutical Supply Chain Initiative (PSCI) membership [2]
Charles River's excellence in workplace culture and diversity has earned significant recognition in 2024, including:
- America's Greatest Workplaces for Diversity (Newsweek)
- Best Place to Work for Disability Inclusion in Canada, UK, and US
- Montreal's Top Employers
- Great Place to Work Singapore [1]
Strategic achievements in 2024 demonstrate the company's ongoing evolution:
- Attainment of 100% renewable electricity goal
- UNGC signatory status
- Expansion of global STEM education initiatives
- Implementation of inclusive interview panels and bias mitigation training [1]
The organization continues to strengthen its commitment to scientific innovation while maintaining comprehensive quality management systems aligned with pharmaceutical and healthcare industry standards [3]. Regular audits by regulatory bodies, including the FDA, State of California, and AABB, ensure consistent adherence to quality standards and compliance requirements [3].